A case of thyroiditis during natalizumab therapy for multiple sclerosis

被引：0
作者：
S. Oddo
A. Laroni
A. Uccelli
M. Giusti
机构：
[1] University of Genova,Department of Endocrinology and Medical Science
[2] University of Genova,Department of Neuroscience, Ophtalmology and Genetics
来源：
Journal of Endocrinological Investigation | 2011年 / 34卷
关键词：
Multiple Sclerosis; Sorafenib; Sunitinib; Thyroiditis; Alemtuzumab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：408 / 409
页数：1
相关论文
共 50 条
  • [41] Use of natalizumab in multiple sclerosis: current perspectives
    Gandhi, Sirin
    Jakimovski, Dejan
    Ahmed, Rahil
    Hojnacki, David
    Kolb, Channa
    Weinstock-Guttman, Bianca
    Zivadinov, Robert
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2016, 16 (09) : 1151 - 1162
  • [42] Why patients with multiple sclerosis perceive improvement of gait during treatment with natalizumab?
    Klara Novotna
    Jan Rusz
    Eva Kubala Havrdova
    Jana Lizrova Preiningerova
    Journal of Neural Transmission, 2019, 126 : 731 - 737
  • [43] Natalizumab in relapsing-remitting multiple sclerosis
    Outteryck, Olivier
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2016, 16 (05) : 471 - 481
  • [44] Multiple sclerosis: the ongoing natalizumab story and more
    Strupp, Michael
    JOURNAL OF NEUROLOGY, 2009, 256 (02) : 293 - 293
  • [45] Multiple sclerosis: the ongoing natalizumab story and more
    Michael Strupp
    Journal of Neurology, 2009, 256 : 293 - 295
  • [46] Best practice in the use of natalizumab in multiple sclerosis
    Fernandez, Oscar
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2013, 6 (02) : 69 - 79
  • [47] Pharmacotherapy Options for Multiple Sclerosis: Focus on Natalizumab
    Stangel, Martin
    Kieseier, Bernd C.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 947 - 952
  • [48] Blocking adhesion molecules with natalizumab in multiple sclerosis
    Schreiner, B
    Kieseier, BC
    Hartung, HR
    Hohlfeld, R
    Wiendl, H
    NERVENARZT, 2005, 76 (08): : 999 - 1005
  • [49] Best practice recommendations for the selection and management of patients with multiple sclerosis receiving natalizumab therapy
    Coyle, Patricia K.
    Foley, John F.
    Fox, Edward J.
    Jeffery, Douglas R.
    Munschauer, Frederick E., III
    Tornatore, Carlo
    MULTIPLE SCLEROSIS JOURNAL, 2009, 15 : S26 - S36
  • [50] The Italian Pharmacovigilance Program: An Observational Study of Adverse Effects of Natalizumab in Multiple Sclerosis Therapy
    Giacoppo, Sabrina
    Ruscica, Maria
    Grimaldi, Luigi Maria
    Bramanti, Placido
    Mazzon, Emanuela
    MEDICAL SCIENCE MONITOR, 2017, 23 : 4230 - 4240
12345